SERUM FERRITIN AND SERUM LACTATE DEHYDROGENASE LEVELS AMONG COVID-19 PATIENTS

Objectives: The aim of this study was to estimate serum ferritin and serum lactate dehydrogenase (LDH) values among COVID-19-positive and COVID-19-negative subjects. Methods: The study was conducted on 152 cases; 76 were COVID-19 diseased, and 76 were COVID-19 free. Serum ferritin and serum LDH leve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Asian journal of pharmaceutical and clinical research 2024-01, p.30-32
1. Verfasser: KAPARUWAN, ASTHA
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives: The aim of this study was to estimate serum ferritin and serum lactate dehydrogenase (LDH) values among COVID-19-positive and COVID-19-negative subjects. Methods: The study was conducted on 152 cases; 76 were COVID-19 diseased, and 76 were COVID-19 free. Serum ferritin and serum LDH levels were estimated. Result: Average ferritin levels among COVID-19 diseased were 529.33 ng/ml compared to 450.92 ng/ml among negative individuals. Similarly, the LDH level among positive persons was 338.50 IU/L and 303.30 IU/L among hostile people. Conclusion: The uncontrolled and dysfunctional immune response is connected with macrophage activation and hyperferritinemic syndrome. Elevated LDH readings seem to reflect that multiple organ injury and failure may play a more prominent role in influencing the clinical outcomes in patients with COVID-19.
ISSN:0974-2441
0974-2441
DOI:10.22159/ajpcr.2024.v17i1.49572